Skip to main navigation Skip to search Skip to main content

Havrix Administered concomitantly with a measles-mumps-rubella vaccine

Project: Research

Project Details

StatusFinished
Effective start/end date08/30/01 → 07/22/02

Funding

  • SmithKline Beecham: $1,127.10